Debie J. Hoivik

1.3k citations

25 papers · 1.1k indexed · h-index 14

Co-authors: Stephen Safe Weston W. Porter Thu Annelise Nguyen Jeong‐Eun Lee Steven D. Cohen Edward A. Khairallah Richard S. Pollenz José E. Manautou
Topics: Drug-Induced Hepatotoxicity and Protection (8 papers)Peroxisome Proliferator-Activated Receptors (8 papers)Drug Transport and Resistance Mechanisms (7 papers)
Cited by: Pharmacology Genetics Health, Toxicology and Mutagenesis
Journals: Nucleic Acids Research Journal of Biological Chemistry Journal of Pharmacology and Experimental Therapeutics
Partner nations: United States United Kingdom Netherlands

In The Last Decade

Debie J. Hoivik

24 papers receiving 1.0k citations

Peers

Countries citing papers authored by Debie J. Hoivik

Since Specialization

Citations

This map shows the geographic impact of Debie J. Hoivik's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Debie J. Hoivik with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Debie J. Hoivik more than expected).

Fields of papers citing papers by Debie J. Hoivik

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Debie J. Hoivik. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Debie J. Hoivik. The network helps show where Debie J. Hoivik may publish in the future.

Co-authorship network of co-authors of Debie J. Hoivik

This figure shows the co-authorship network connecting the top 25 collaborators of Debie J. Hoivik. A scholar is included among the top collaborators of Debie J. Hoivik based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Debie J. Hoivik. Debie J. Hoivik is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Assessing the Carcinogenicity of Vadadustat, an Oral Hypoxia-Inducible Factor Prolyl-4-Hydroxylase Inhibitor, in Rodents 2023 ·Toxicologic Pathology ·(unknown),Debie J. Hoivik,Michael H. Rabinowitz	0
2	Preclinical Characterization of Vadadustat (AKB-6548), an Oral Small Molecule Hypoxia-Inducible Factor Prolyl-4-Hydroxylase Inhibitor, for the Potential Treatment of Renal Anemia 2022 ·Journal of Pharmacology and Experimental Therapeutics ·Anna Żuk,Zhihai Si,(unknown),(unknown),Debie J. Hoivik,Sanjay Danthi,(unknown),Vilmos Csizmadia,Michael H. Rabinowitz	17
3	Gene Expression Profiling of the PPAR-alpha Agonist Ciprofibrate in the Cynomolgus Monkey Liver 2005 ·Toxicological Sciences ·Neal F. Cariello,Elizabeth H. Romach,Heidi M. Colton,Hong Ni,Lawrence Yoon,(unknown),Warren Casey,(unknown),Steven P. Anderson,(unknown),Debie J. Hoivik,(unknown),Richard T. Miller	65
4	Evaluation of the Carcinogenic Potential of Clofibrate in the FVB/Tg.AC Mouse After Dermal Application—Part II 2005 ·International Journal of Toxicology ·(unknown),(unknown),James A. Campbell,(unknown),Debie J. Hoivik,Richard T. Miller,Jane S. Allen,Manuel J. Jayo,(unknown),Michael J. Santostefano	7
5	Fibrates induce hepatic peroxisome and mitochondrial proliferation without overt evidence of cellular proliferation and oxidative stress in cynomolgus monkeys 2004 ·Carcinogenesis ·Debie J. Hoivik,Charles W. Qualls,Rosanna C. Mirabile,Neal F. Cariello,(unknown),Heidi M. Colton,Steven P. Anderson,Michael J. Santostefano,(unknown),(unknown),Alan R. Brown,Zhiyang Zhao,Paul N. Mudd,(unknown),H. Roger Brown,Richard T. Miller	56
6	CYP3A INDUCTION BY N-HYDROXYFORMAMIDE TUMOR NECROSIS FACTOR-α CONVERTING ENZYME/MATRIX METALLOPROTEINASE INHIBITORS: USE OF A PREGNANE X RECEPTOR ACTIVATION ASSAY AND PRIMARY HEPATOCYTE CULTURE FOR ASSESSING INDUCTION POTENTIAL IN HUMANS 2003 ·Drug Metabolism and Disposition ·Timothy K. Tippin,Geraldine A. Hamilton,Linda B. Moore,(unknown),Summer Jolley,Thomas A. Brodie,Robert Andrews,J. David Becherer,Darryl McDougald,Michael D. Gaul,Debie J. Hoivik,(unknown),Jürgen Lehmann,Steven A. Kliewer,Steven Novick,(unknown),Zhiyang Zhao,Edward L. LeCluyse	8
7	Interactions of Nuclear Receptor Coactivator/Corepressor Proteins with the Aryl Hydrocarbon Receptor Complex 1999 ·Archives of Biochemistry and Biophysics ·Thu Annelise Nguyen,Debie J. Hoivik,Jeong‐Eun Lee,Stephen Safe	116
8	ALTERED PHENOTYPIC CHARACTERISTICS OF T47D HUMAN BREAST CANCER CELLS AFTER PROLONGED GROWTH IN ESTROGEN‐DEFICIENT MEDIUM 1998 ·Cell Biology International ·(unknown),Cody Wilson,Debie J. Hoivik,Stephen Safe	9
9	Functional and physical interactions between the estrogen receptor Sp1 and nuclear aryl hydrocarbon receptor complexes 1998 ·Nucleic Acids Research ·(unknown),Debie J. Hoivik,Richard S. Pollenz,Stephen Safe	97
10	Studies on the Relationship between Estrogen Receptor Content, GlutathioneS-Transferase π Expression, and Induction by 2,3,7,8-Tetrachlorodibenzo-p-dioxin and Drug Resistance in Human Breast Cancer Cells 1997 ·Archives of Biochemistry and Biophysics ·Debie J. Hoivik,Cody Wilson,(unknown),(unknown),Rola Barhoumi,Robert C. Burghardt,Stephen Safe	11
11	Aryl Hydrocarbon (Ah) Nonresponsiveness in Estrogen Receptor-Negative MDA-MB-231 Cells Is Associated with Expression of a Variant Arnt Protein 1997 ·Archives of Biochemistry and Biophysics ·Cody Wilson,Jane S. Thomsen,Debie J. Hoivik,Mark Wormke,Larry H. Stanker,Carol K. Holtzapple,Stephen Safe	33
12	Estrogen Does Not Inhibit 2,3,7,8-Tetrachlorodibenzo-p-dioxin-mediated Effects in MCF-7 and Hepa 1c1c7 Cells 1997 ·Journal of Biological Chemistry ·Debie J. Hoivik,(unknown),Cody Wilson,Stephen Safe	56
13	Functional Synergy between the Transcription Factor Sp1 and the Estrogen Receptor 1997 ·Molecular Endocrinology ·Weston W. Porter,(unknown),Debie J. Hoivik,Stephen Safe	339
14	Protection by Clofibrate against Acetaminophen Hepatotoxicity in Male CD-1 Mice Is Associated with an Early Increase in Biliary Concentration of Acetaminophen–Glutathione Adducts 1996 ·Toxicology and Applied Pharmacology ·José E. Manautou,(unknown),Debie J. Hoivik,Edward A. Khairallah,Steven D. Cohen	34
15	Evidence Suggesting the 58-kDa Acetaminophen Binding Protein Is a Preferential Target for Acetaminophen Electrophile 1996 ·Toxicological Sciences ·Debie J. Hoivik,José E. Manautou,(unknown),(unknown),Edward A. Khairallah,Steven D. Cohen	2
16	Evidence Suggesting the 58-kDa Acetaminophen Binding Protein Is a Preferential Target for Acetaminophen Electrophile 1996 ·Fundamental and Applied Toxicology ·Debie J. Hoivik	25
17	Protein Arylation Precedes Acetaminophen Toxicity in a Dynamic Organ Slice Culture of Mouse Kidney 1996 ·Fundamental and Applied Toxicology ·Debie J. Hoivik	16
18	Protein Arylation Precedes Acetaminophen Toxicity in a Dynamic Organ Slice Culture of Mouse Kidney 1996 ·Toxicological Sciences ·Debie J. Hoivik,Robyn L. Fisher,Klaus Brendel,A. Jay Gandolfi,Edward A. Khairallah,Steven D. Cohen	2
19	Gender-Related Differences in Susceptibility to Acetaminophen-Induced Protein Arylation and Nephrotoxicity in the CD-1 Mouse 1995 ·Toxicology and Applied Pharmacology ·Debie J. Hoivik,José E. Manautou,(unknown),Susan Hart,Edward A. Khairallah,Steven D. Cohen	49
20	Clofibrate Pretreatment Diminishes Acetaminophen′s Selective Covalent Binding and Hepatotoxicity 1994 ·Toxicology and Applied Pharmacology ·José E. Manautou,Debie J. Hoivik,(unknown),Susan Hart,Edward A. Khairallah,Steven D. Cohen	55

About Debie J. Hoivik

Debie J. Hoivik is a scholar working on Pharmacology, Hepatology and Oncology, having authored 25 papers that have together received 1.1k indexed citations. Recurring topics across this work include Drug-Induced Hepatotoxicity and Protection (8 papers), Peroxisome Proliferator-Activated Receptors (8 papers) and Drug Transport and Resistance Mechanisms (7 papers). The work is most often cited by research in Pharmacology (215 citations), Genetics (387 citations) and Health, Toxicology and Mutagenesis (170 citations). Debie J. Hoivik has collaborated with scholars based in United States, United Kingdom and Netherlands. Frequent co-authors include Stephen Safe, Weston W. Porter, Thu Annelise Nguyen, Stephen Safe, Jeong‐Eun Lee, Steven D. Cohen, Edward A. Khairallah, Richard S. Pollenz, José E. Manautou and Cody Wilson. Their work appears in journals such as Nucleic Acids Research, Journal of Biological Chemistry and Journal of Pharmacology and Experimental Therapeutics.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact